Claritev financials
$21.17−2.17%
Close Sep 30, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 |
|---|---|---|---|---|---|---|
| Revenue | $257.5M | $244.7M | $246.6M | $246.0M | $241.6M | $231.3M |
| Gross profit | $189.8M | $175.6M | $176.5M | $183.9M | $180.7M | $170.9M |
| Gross margin | 73.7% | 71.8% | 71.6% | 74.8% | 74.8% | 73.9% |
| Operating income | $23.7M | $6.7M | $8.7M | $10.1M | $18.4M | $13.4M |
| Net income | -$59.2M | -$73.6M | -$80.6M | -$69.8M | -$62.6M | -$71.3M |
| Net margin | −23.0% | −30.1% | −32.7% | −28.4% | −25.9% | −30.8% |
| Diluted EPS | $-3.49 | $-4.41 | $-4.87 | $-4.23 | $-3.81 | $-4.38 |
| EBITDA | $134.4M | $117.8M | $120.4M | $122.0M | $129.6M | $123.9M |
| Operating cash flow | $92.7M | -$45.8M | $66.3M | $19.9M | $61.2M | -$30.1M |
| Free cash flow | $54.6M | -$92.5M | $36.4M | -$16.3M | $36.6M | -$68.9M |
| Diluted shares | 17.0M | 16.7M | 16.5M | 16.5M | 16.5M | 16.3M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $14.4M | $21.3M | $16.8M | $39.2M | $56.4M | $23.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $4.77B | $4.77B | $4.70B | $4.69B | $4.73B | $4.67B |
| Total assets | $4.76B | $4.84B | $4.89B | $4.99B | $5.07B | $5.08B |
| Total liabilities | $5.05B | $5.07B | $5.06B | $5.09B | $5.11B | $5.07B |
| Shareholders' equity | -$287.8M | -$234.4M | -$167.2M | -$101.8M | -$39.9M | $14.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology